2023EHA好声音 | 新诊断多发性骨髓瘤进展速递 2023 EHA 2023年第28届欧洲血液学大会/年会(28th EHA Congress)将于2023年6月8-11日在德国法兰克福举行,会议由欧洲血液学会(EHA)主办。 EHA年会是全球血液学领域规模最大的国际会议之一,大会主题涵盖了血液学...
例如:当地时间2023年05月11日星期四08:00 AM,即为北京时间2023年05月11日星期四14:00 PM。 不可避免的信息差: EHA 2023日程可能会根据实际情况进行调整,故详情请以后续的最新报道内容或官网的最新发布内容为准。 英文日程 以下为部分重要日程摘要,...
The European Hematology Association (EHA) Hybrid Congress will take place on June 8-15, 2023 in Francfurt, Germany Cellectis will present, in a poster session, updated clinical and translational data on its BALLI-01 clinical trial (evaluating UCART22) in patients with relapsed/refractory B-cell...
2023年第28届欧洲血液学大会/年会(EHA2023 Hybrid Congress)于2023年6月8日至11日在德国法兰克福举行,会议由欧洲血液学会(EHA)举办。EHA大会是全球血液学领域规模最大的国际会议之一,涵盖了血液学研究的各个方面主题,分享探讨有关血液学的创新理念及最新的科学和临床研究成果。北京大学人民医院发布了一项关于超高灵敏N...
◆ 会议时间:2023年6月8日至11日 ◆ 会议地点:德国 法兰克福 ◆ 下次会议:2024年第29届欧洲血液学年会(EHA2024) ◆ 会议简介: 2023年第28届欧洲血液学大会/年会(28th EHA Congress)将于2023年6月8日至11日在德国法兰克福举行,会议由欧洲血液学会(EHA)主办。欧洲血液年会(EHA年会)是全球血液学领域规模最大的...
Welcome to the Congress Mobile App of the EHA2023 Hybrid Congress. The European Hematology Association promotes excellence in patient care, research, and education in hematology. EHA serves medical professionals, researchers, and scientists with an active interest in hematology and is proud to be the...
EHA''s dedication to excellence in patient care, research, and education in hematology is realized in bringing together professionals from all parts of the. Congress of EHA 2023 is held in Frankfurt, Germany, from 6/8/2023 to 6/8/2023 in Messe Frankfurt.
The EHA2023 Hybrid Congress will be live-streamed and taking place from June 8-11, 2023 in Frankfurt, and live-streamed (virtual) only from June 14-15. For participants who attended in Frankfurt, the Congress Mobile App is the Congress in the palm of your hands. Via the Congress Mobile...
intriguing. I think there was also some recent presentation on resistance to menin inhibitors at this congress that I found to be very interesting and intriguing. So I think it was a good congress, and we've had some very recent developments at this congress and also other meetings globally...
Johnson & Johnson presentations at EHA 2024 Congress: Multiple Myeloma Oral Presentations Abstract #S201 Daratumumab plus bortezomib/lenalidomide/dexamethasone in transplant-eligible patients with NDMM: analysis of MRD in the PERSEUS trial Ab...